Publications

2015

Finnerty BM, Kleiman DA, Scognamiglio T, Aronova A, Beninato T, Fahey TJ, et al. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol. 2015;22(4):1200-6.
Yang C, Boyson CA, Di Liberto M, Huang X, Hannah J, Dorn DC, et al. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer Res. 2015;75(9):1838-45.
Boysen G, Barbieri CE, Prandi D, Blattner M, Chae S-, Dahija A, et al. SPOP mutation leads to genomic instability in prostate cancer. Elife. 2015;4.
Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, Loda M, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015;34(36):4683-91.
Kiuru M, Camp B, Adhami K, Jacob V, Magro C, Wildman H. Treatment of metastatic cutaneous Crohn disease with certolizumab. Dermatol Online J. 2015;21(11).
Wilhelmus S, Alpers CE, H Cook T, Ferrario F, Fogo AB, Haas M, et al. The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions. J Am Soc Nephrol. 2015;26(12):2938-46.
Roma AA, Goyal A, Yang B. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions. Int J Gynecol Pathol. 2015;34(5):480-6.
Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson S-, et al. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015;13(10):1431-40.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700